CDX-0159

· Celldex Therapeutics

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for CDX-0159, covering 2025-03-26 to 2026-01-30. Get the full timeline:

Most recent: Clinical Trial Update: A Study of CDX-0159 in Patients With Eosinophilic Esophagitis [Phase 2]